Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Daniela Rozkova"'
Autor:
Michal Hensler, Jana Rakova, Lenka Kasikova, Tereza Lanickova, Josef Pasulka, Peter Holicek, Marek Hraska, Tereza Hrnciarova, Pavla Kadlecova, Andreu Schoenenberger, Klara Sochorova, Daniela Rozkova, Ludek Sojka, Jana Drozenova, Jan Laco, Rudolf Horvath, Michal Podrazil, Guo Hongyan, Tomas Brtnicky, Michal J. Halaska, Lukas Rob, Ales Ryska, An Coosemans, Ignace Vergote, Abhishek D. Garg, David Cibula, Jirina Bartunkova, Radek Spisek, Jitka Fucikova
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Dendritic cells (DCs) have received considerable attention as potential targets for the development of novel cancer immunotherapies. However, the clinical efficacy of DC-based vaccines remains suboptimal, largely reflecting local and systemic immunos
Externí odkaz:
https://doaj.org/article/8aa6cc35d16f49fbb0529e5fcefe2e0f
Autor:
Radek Spisek, Lorenzo Galluzzi, Jérôme Galon, Jirina Bartunkova, David Cibula, Ignace Vergote, An Coosemans, Ales Ryska, Lukas Rob, Michael J. Halaska, Ivan Praznovec, Tomas Brtnicky, Jan Laco, Pavel Dundr, Ludek Sojka, Daniela Rozkova, Klara Sochorova, Tereza Hrnciarova, Marek Hraska, Tessa Fredriksen, Jana Drozenova, Jana Rakova, Josef Pasulka, Tereza Lanickova, Lenka Kasikova, Michal Hensler, Jitka Fucikova
Purpose:The successful implementation of immune checkpoint inhibitors (ICI) in the clinical management of various solid tumors has raised considerable expectations for patients with epithelial ovarian carcinoma (EOC). However, EOC is poorly responsiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2edf464bb0e75cf494ef22f2a9c051d7
https://doi.org/10.1158/1078-0432.c.6532535.v1
https://doi.org/10.1158/1078-0432.c.6532535.v1
Autor:
Radek Spisek, Lorenzo Galluzzi, Jérôme Galon, Jirina Bartunkova, David Cibula, Ignace Vergote, An Coosemans, Ales Ryska, Lukas Rob, Michael J. Halaska, Ivan Praznovec, Tomas Brtnicky, Jan Laco, Pavel Dundr, Ludek Sojka, Daniela Rozkova, Klara Sochorova, Tereza Hrnciarova, Marek Hraska, Tessa Fredriksen, Jana Drozenova, Jana Rakova, Josef Pasulka, Tereza Lanickova, Lenka Kasikova, Michal Hensler, Jitka Fucikova
Supplementary Figure from An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e506ae0712ba6bc0b2b40bb8ae64b8e
https://doi.org/10.1158/1078-0432.22487537.v1
https://doi.org/10.1158/1078-0432.22487537.v1
Autor:
Radek Spisek, Lorenzo Galluzzi, Jérôme Galon, Jirina Bartunkova, David Cibula, Ignace Vergote, An Coosemans, Ales Ryska, Lukas Rob, Michael J. Halaska, Ivan Praznovec, Tomas Brtnicky, Jan Laco, Pavel Dundr, Ludek Sojka, Daniela Rozkova, Klara Sochorova, Tereza Hrnciarova, Marek Hraska, Tessa Fredriksen, Jana Drozenova, Jana Rakova, Josef Pasulka, Tereza Lanickova, Lenka Kasikova, Michal Hensler, Jitka Fucikova
Supplementary Data from An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4b7a2a67f69a0b15d6f449d601cab1
https://doi.org/10.1158/1078-0432.22487543
https://doi.org/10.1158/1078-0432.22487543
Autor:
Jitka Fucikova, Michal Hensler, Lenka Kasikova, Tereza Lanickova, Josef Pasulka, Jana Rakova, Jana Drozenova, Tessa Fredriksen, Marek Hraska, Tereza Hrnciarova, Klara Sochorova, Daniela Rozkova, Ludek Sojka, Pavel Dundr, Jan Laco, Tomas Brtnicky, Ivan Praznovec, Michael J. Halaska, Lukas Rob, Ales Ryska, An Coosemans, Ignace Vergote, David Cibula, Jirina Bartunkova, Jérôme Galon, Lorenzo Galluzzi, Radek Spisek
Publikováno v:
Clinical Cancer Research. 28:3053-3065
Purpose: The successful implementation of immune checkpoint inhibitors (ICI) in the clinical management of various solid tumors has raised considerable expectations for patients with epithelial ovarian carcinoma (EOC). However, EOC is poorly responsi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d6adcc1c87afbc68f7cd5362c08d37b
https://doi.org/10.1158/1078-0432.ccr-21-4413
https://doi.org/10.1158/1078-0432.ccr-21-4413
Autor:
Jitka Fucikova, Sarka Vosahlikova, Radek Spisek, Jirina Bartunkova, Anne-Marie Chalupova, Klara Sochorova, Daniela Rozkova, Lenka Palová-Jelínková
Dendritic cells have been widely investigated in cancer immunotherapy clinical trials for the last two decades mainly due to their robust ability to elicit an adaptive anticancer immune response of the cellular and humoral types. Immature DCs can be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a3db390e3b33e27e09bd8ee64c02433
https://doi.org/10.1016/bs.mie.2019.05.045
https://doi.org/10.1016/bs.mie.2019.05.045
Autor:
Jana Klouckova, Zdenka Gasova, Jitka Fucikova, Jirina Bartunkova, Anna Fialová, Daniela Rozkova, Michal Podrazil, Klara Sochorova, Etienne Becht, Pavla Bilkova, Rudolf Horvath, Jana Kayserova, Radek Spisek, Katerina Vavrova, Ladislav Jarolím, Michal Hensler
Publikováno v:
Cancer Immunology, Immunotherapy. 67:89-100
Immunotherapy of cancer has the potential to be effective mostly in patients with a low tumour burden. Rising PSA (prostate-specific antigen) levels in patients with prostate cancer represents such a situation. We performed the present clinical study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f88322b798542ee558a056494adfc53c
https://doi.org/10.1007/s00262-017-2068-x
https://doi.org/10.1007/s00262-017-2068-x
Autor:
Daniela Rozkova, Anna Sediva, Veronika Skalická, V. Budinsky, Petr Pohunek, E. Vernerova, Jana Kayserova, I. Zentsova-Jaresova, Jana Kopecka, Radek Spisek
Publikováno v:
Scandinavian Journal of Immunology. 75:305-313
Dendritic cells (DCs) are specific antigen-presenting cells that play critical roles in the initiation and polarization of immune responses. DCs residing in the lungs might be detected in the bronchoalveolar lavage fluid (BALF). We analysed DC compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4fed5abf56da3686dd50d7dd6b12fcf
https://doi.org/10.1111/j.1365-3083.2011.02649.x
https://doi.org/10.1111/j.1365-3083.2011.02649.x
Autor:
Zdenek Linke, Jana Prausová, Michal Podrazil, Jirina Bartůnková, Jitka Fucikova, Anna Sediva, Vít Budinský, Hana Ulcová, Ivo Minárik, Daniela Rozkova, Radek Spisek, Hana Tiserová, Jan Lastovicka
Publikováno v:
Clinical Immunology. 131:1-10
Immunotherapy has emerged as another treatment modality in cancer. The goal of immunotherapy in advanced cancer patients does not have to be the complete eradication of tumor cells but rather the restoration of a dynamic balance between tumor cells a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30a8a2e66ec0728d5af18892ad410689
https://doi.org/10.1016/j.clim.2009.01.001
https://doi.org/10.1016/j.clim.2009.01.001
Autor:
Jirina Bartunkova, Jiri Litzman, Radek Spisek, Anna Sediva, Daniela Rozkova, Rudolf Horvath, Klara Sochorova
Publikováno v:
Blood. 109:2553-2556
The critical role of Bruton tyrosine kinase (Btk) in B cells has been documented by the block of B-cell development in X-linked agammaglobulinemia (XLA). Less is known about Btk function in myeloid cells. Several pieces of evidence indicate that Btk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60b79aaa7b3cdac499e68f27686d6e66
https://doi.org/10.1182/blood-2006-07-037960
https://doi.org/10.1182/blood-2006-07-037960